Key Takeaways

  • A Race Against Blindness has committed an additional $1 million to support gene-agnostic therapies for inherited retinal diseases

  • A $300,000 research award will support PROX1-targeted retinal regeneration research that has demonstrated restored visual function in animal models of RP.

The Foundation Fighting Blindness and its venture philanthropy arm, the Gund Vision Fund, have announced a second $1 million commitment from A Race Against Blindness to advance gene-agnostic therapies for inherited retinal diseases, including retinitis pigmentosa (RP).

The new funding follows an initial $1 million commitment earlier in 2026 and will allocate $700,000 to the Gund Vision Fund and $300,000 to a Foundation Fighting Blindness research award. The Gordon and Llura Gund Foundation Challenge will match the Fund's allocation dollar for dollar, increasing its total funding impact to $1.4 million.

The Gund Vision Fund will use the investment to support gene-agnostic therapeutic strategies designed to benefit patients regardless of their underlying genetic mutations. Its portfolio includes neuroprotective approaches to slow retinal degeneration, optogenetics-inspired therapies to restore light sensitivity, and cell-based treatments targeting photoreceptor function.

The remaining $300,000 will support preclinical regenerative research led by Jin Woo Kim, PhD, at the Korea Advanced Institute of Science and Technology (KAIST). Dr. Kim's research focuses on inhibiting PROX1, a protein that prevents Müller glial cells from regenerating. Using an antibody to block PROX1 activity, investigators aim to reprogram Müller glia into retinal progenitor-like cells capable of developing into new photoreceptors. The approach has demonstrated restoration of visual function in animal models of RP. The funding will support antibody optimization, improvements in delivery, and advancement of promising candidates toward large-animal studies and eventual first-in-human trials.

Founded in 2023 by Stephen Johnston and Kristina Johnston following their son's diagnosis of RP associated with Bardet-Biedl syndrome, A Race Against Blindness has directed more than $7 million toward research targeting these conditions.